[
  {
    "ts": null,
    "headline": "Is Abbott Laboratories Fairly Priced After Growth In Devices And Diagnostics?",
    "summary": "Wondering if Abbott Laboratories at around $125 a share is still a smart buy or if the best days are already priced in? You are not alone, and this breakdown is designed to give you a clear, valuation first answer. The stock is roughly flat over the last month at down 0.3%, but it is still up 10.5% year to date and over the past year, hinting that the market sees steady, not explosive, upside for now. Recent headlines have focused on Abbott's continued expansion of its medical devices and...",
    "url": "https://finnhub.io/api/news?id=46de22392acd5d553d3d226b88c382efea2892523cd509977080180007abd04c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764954604,
      "headline": "Is Abbott Laboratories Fairly Priced After Growth In Devices And Diagnostics?",
      "id": 137715717,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Wondering if Abbott Laboratories at around $125 a share is still a smart buy or if the best days are already priced in? You are not alone, and this breakdown is designed to give you a clear, valuation first answer. The stock is roughly flat over the last month at down 0.3%, but it is still up 10.5% year to date and over the past year, hinting that the market sees steady, not explosive, upside for now. Recent headlines have focused on Abbott's continued expansion of its medical devices and...",
      "url": "https://finnhub.io/api/news?id=46de22392acd5d553d3d226b88c382efea2892523cd509977080180007abd04c"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights HSBC, Abbott, Shell and Oak Valley",
    "summary": "HSBC, Abbott, Shell and Oak Valley feature in the latest Zacks Analyst Blog as analysts highlight operational resilience, strategic pivots and industry-specific challenges.",
    "url": "https://finnhub.io/api/news?id=667e6e721609e6e2f5ddea04272ce77a7c3860d061a2096f1eb448532119975b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764933120,
      "headline": "The Zacks Analyst Blog Highlights HSBC, Abbott, Shell and Oak Valley",
      "id": 137697147,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "HSBC, Abbott, Shell and Oak Valley feature in the latest Zacks Analyst Blog as analysts highlight operational resilience, strategic pivots and industry-specific challenges.",
      "url": "https://finnhub.io/api/news?id=667e6e721609e6e2f5ddea04272ce77a7c3860d061a2096f1eb448532119975b"
    }
  }
]